Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avidity Biosciences, Inc. - Common Stock (NQ:RNA)

69.85 +0.16 (+0.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avidity Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Here's Why Avidity Biosciences Stock Soared This Week (There's More to the Deal Than You Might Think)
Novartis is set to boost its developmental pipeline with this acquisition. 
Via The Motley Fool
Unusual volume stocks in Thursday's session
Discover the stocks with unexpected trading volume in today's session on the US markets. 
Via Chartmill
$1000 Invested In Avidity Biosciences 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
RNA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Avidity Biosciences, Inc. is Fair to Shareholders
Shareholders should contact the firm immediately as there may be limited time to enforce your rights 
From Halper Sadeh LLC
Via GlobeNewswire
Dyne Therapeutics Stock Soars After Rival Avidity Biosciences Gets Acquired By Novartis
Via Stocktwits
Dow Futures Rise As China Trade Tensions Ease: NVDA, MP, BA, RNA Among Stocks To Watch
Via Stocktwits
Topics Stocks World Trade
Nucor To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
This Boot Barn Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
 
Via Benzinga
Novartis Maintains Outlook Even As Generics Bite Into Profits
Novartis Q3 sales rose 8% to $13.91 billion, missing estimates, as Kisqali and Kesimpta drove growth while U.S. generics weighed on results. 
Via Benzinga
RNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avidity Biosciences, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
'Merger Monday' Makes Comeback As US M&A Tops $80 Billion In 24 Hours
U.S. companies have struck more than $80 billion worth of deals in the past 24 hours, in the latest sign that mergers and acquisitions (M&A) are picking up after the tariff-induced cool-off earlier... 
Via Benzinga
Avidity Biosciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avidity Biosciences, Inc. - RNA
From Kahn Swick & Foti, LLC
Via Business Wire
Wall Street Soars as Qualcomm Ignites the AI Race
Investor optimism drives the S&P 500 to new records while Qualcomm steals the spotlight with an 11% surge after unveiling new AI chips. 
Via Chartmill
Topics Artificial Intelligence Stocks
Why Avidity Biosciences Stock Blasted 42% Higher Today
If all goes well, the company will be part of a much larger enterprise starting next year. 
Via The Motley Fool
Which stocks are moving on Monday?
Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Essential Utilities, Inc. (NYSE – WTRG), Cadence Bank (NYSE – CADE), Avidity Biosciences, Inc. (Nasdaq – RNA), Plymouth Industrial REIT, Inc. (NYSE – PLYM)
From Brodsky & Smith LLC
Via GlobeNewswire
Avidity Biosciences Soars After $72 Per Share Novartis Takeover
Avidity Biosciences (RNA) to be acquired by Novartis in a $12 billion cash deal. H.C. Wainwright downgrades to Neutral. 
Via Benzinga
Qualcomm, Tesla, Intellia Therapeutics, Avidity Biosciences, Dyne Therapeutics: Stocks Making The Biggest Moves Today
Qualcomm shares were up more than 11% in Monday’s midday session after the company unveiled two AI accelerator chips. 
Via Stocktwits
Topics Artificial Intelligence ETFs Government
Keep an eye on the top gainers and losers in Monday's session.
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Which stocks are gapping on Monday?
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
Via Chartmill
Janus Henderson, Avidity Biosciences, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
These stocks are moving in today's pre-market session
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday
 
Via Benzinga
This Harley-Davidson Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
 
Via Benzinga
Avidity Shareholders Win Big As Novartis Moves Fast On $12 Billion Deal
Avidity Biosciences (NASDAQ: RNA) shares soar as Novartis (NYSE: NVS) agrees to acquire them for $12 billion in cash. 
Via Benzinga
Why Avidity Biosciences Stock Is Jumping Over 43% In Premarket Today
Novartis has agreed to buy Avidity Biosciences in a deal valued at $72 per share. 
Via Stocktwits
Stock Market Today: Dow Jones, S&P 500 Futures Climb Ahead Of Busy Week On Wall Street—Novartis, Nucor, Waste Management In Focus
U.S. stock futures rose on Monday following Friday’s positive moves. Futures of major benchmark indices were higher. 
Via Benzinga
Topics Stocks
Why Avidity Biosciences Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.